Buscar resultados de ensayos clínicos
Peritoneal Neoplasms - 29 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Condición:
Fecha: 2009-11-09 Intervenciones:
|
Completed |
Nombre del estudio: Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma Condición:
Fecha: 2005-09-09 Intervenciones: Drug: Docetaxel and Gemcitabine Docetaxel 75 mg/m2 IV over 15-30 minutes on day 1 followed by Gemcitabin |
Completed |
Nombre del estudio: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer Condición:
Fecha: 2011-03-08 Intervenciones:
|
Recruiting |
Nombre del estudio: Adjuvant HIPEC in High Risk Colon Cancer Condición:
Fecha: 2014-08-22 Intervenciones:
|
Completed |
Nombre del estudio: Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis Condición:
Fecha: 1999-11-03 Intervenciones: Procedure: CHPP with cisplatin |
Completed |
Nombre del estudio: Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery Condición:
|
Recruiting |
Nombre del estudio: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición:
|
Completed |
Nombre del estudio: Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis Condición:
|
Completed |
Nombre del estudio: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer Condición:
|